img

Global Rituximab Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rituximab Drug Market Insights, Forecast to 2034

Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer.
Global Rituximab Drug market is expected to reach to US$ 4317 million in 2024, with a positive growth of %, compared with US$ 4125 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rituximab Drug industry is evaluated to reach US$ 5306.7 million in 2029. The CAGR will be 3.5% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Rituximab Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rituximab Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Roche
Teva
Pfizer
Amgen
Segment by Type
500mg
100mg

Segment by Application


Intravenous Use
Subcutaneous Use

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rituximab Drug plant distribution, commercial date of Rituximab Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rituximab Drug introduction, etc. Rituximab Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Rituximab Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Rituximab Drug Product Introduction
1.2 Market by Type
1.2.1 Global Rituximab Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 500mg
1.2.3 100mg
1.3 Market by Application
1.3.1 Global Rituximab Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Intravenous Use
1.3.3 Subcutaneous Use
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rituximab Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Rituximab Drug Revenue by Region
2.2.1 Global Rituximab Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Rituximab Drug Revenue by Region (2018-2024)
2.2.3 Global Rituximab Drug Revenue by Region (2024-2029)
2.2.4 Global Rituximab Drug Revenue Market Share by Region (2018-2029)
2.3 Global Rituximab Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Rituximab Drug Sales by Region
2.4.1 Global Rituximab Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Rituximab Drug Sales by Region (2018-2024)
2.4.3 Global Rituximab Drug Sales by Region (2024-2029)
2.4.4 Global Rituximab Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rituximab Drug Sales by Manufacturers
3.1.1 Global Rituximab Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Rituximab Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rituximab Drug in 2022
3.2 Global Rituximab Drug Revenue by Manufacturers
3.2.1 Global Rituximab Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Rituximab Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rituximab Drug Revenue in 2022
3.3 Global Key Players of Rituximab Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Rituximab Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rituximab Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rituximab Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rituximab Drug, Product Offered and Application
3.8 Global Key Manufacturers of Rituximab Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rituximab Drug Sales by Type
4.1.1 Global Rituximab Drug Historical Sales by Type (2018-2024)
4.1.2 Global Rituximab Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Rituximab Drug Sales Market Share by Type (2018-2029)
4.2 Global Rituximab Drug Revenue by Type
4.2.1 Global Rituximab Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Rituximab Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Rituximab Drug Revenue Market Share by Type (2018-2029)
4.3 Global Rituximab Drug Price by Type
4.3.1 Global Rituximab Drug Price by Type (2018-2024)
4.3.2 Global Rituximab Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Rituximab Drug Sales by Application
5.1.1 Global Rituximab Drug Historical Sales by Application (2018-2024)
5.1.2 Global Rituximab Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Rituximab Drug Sales Market Share by Application (2018-2029)
5.2 Global Rituximab Drug Revenue by Application
5.2.1 Global Rituximab Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Rituximab Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Rituximab Drug Revenue Market Share by Application (2018-2029)
5.3 Global Rituximab Drug Price by Application
5.3.1 Global Rituximab Drug Price by Application (2018-2024)
5.3.2 Global Rituximab Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Rituximab Drug Market Size by Type
6.1.1 US & Canada Rituximab Drug Sales by Type (2018-2029)
6.1.2 US & Canada Rituximab Drug Revenue by Type (2018-2029)
6.2 US & Canada Rituximab Drug Market Size by Application
6.2.1 US & Canada Rituximab Drug Sales by Application (2018-2029)
6.2.2 US & Canada Rituximab Drug Revenue by Application (2018-2029)
6.3 US & Canada Rituximab Drug Market Size by Country
6.3.1 US & Canada Rituximab Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Rituximab Drug Sales by Country (2018-2029)
6.3.3 US & Canada Rituximab Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rituximab Drug Market Size by Type
7.1.1 Europe Rituximab Drug Sales by Type (2018-2029)
7.1.2 Europe Rituximab Drug Revenue by Type (2018-2029)
7.2 Europe Rituximab Drug Market Size by Application
7.2.1 Europe Rituximab Drug Sales by Application (2018-2029)
7.2.2 Europe Rituximab Drug Revenue by Application (2018-2029)
7.3 Europe Rituximab Drug Market Size by Country
7.3.1 Europe Rituximab Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Rituximab Drug Sales by Country (2018-2029)
7.3.3 Europe Rituximab Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rituximab Drug Market Size
8.1.1 China Rituximab Drug Sales (2018-2029)
8.1.2 China Rituximab Drug Revenue (2018-2029)
8.2 China Rituximab Drug Market Size by Application
8.2.1 China Rituximab Drug Sales by Application (2018-2029)
8.2.2 China Rituximab Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rituximab Drug Market Size by Type
9.1.1 Asia Rituximab Drug Sales by Type (2018-2029)
9.1.2 Asia Rituximab Drug Revenue by Type (2018-2029)
9.2 Asia Rituximab Drug Market Size by Application
9.2.1 Asia Rituximab Drug Sales by Application (2018-2029)
9.2.2 Asia Rituximab Drug Revenue by Application (2018-2029)
9.3 Asia Rituximab Drug Sales by Region
9.3.1 Asia Rituximab Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Rituximab Drug Revenue by Region (2018-2029)
9.3.3 Asia Rituximab Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rituximab Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Rituximab Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Rituximab Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Rituximab Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Rituximab Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Rituximab Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Rituximab Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Rituximab Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Rituximab Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Rituximab Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Rituximab Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Roche Rituximab Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Rituximab Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Teva Rituximab Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Rituximab Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Pfizer Rituximab Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Overview
11.4.3 Amgen Rituximab Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Amgen Rituximab Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rituximab Drug Industry Chain Analysis
12.2 Rituximab Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rituximab Drug Production Mode & Process
12.4 Rituximab Drug Sales and Marketing
12.4.1 Rituximab Drug Sales Channels
12.4.2 Rituximab Drug Distributors
12.5 Rituximab Drug Customers
13 Market Dynamics
13.1 Rituximab Drug Industry Trends
13.2 Rituximab Drug Market Drivers
13.3 Rituximab Drug Market Challenges
13.4 Rituximab Drug Market Restraints
14 Key Findings in The Global Rituximab Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rituximab Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 500mg
Table 3. Major Manufacturers of 100mg
Table 4. Global Rituximab Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Rituximab Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Rituximab Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Rituximab Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Rituximab Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Rituximab Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Rituximab Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Rituximab Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Rituximab Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Rituximab Drug Sales Market Share by Region (2018-2024)
Table 14. Global Rituximab Drug Sales Market Share by Region (2024-2029)
Table 15. Global Rituximab Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Rituximab Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Rituximab Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Rituximab Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Rituximab Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Rituximab Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Rituximab Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rituximab Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rituximab Drug as of 2022)
Table 23. Global Key Manufacturers of Rituximab Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Rituximab Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Rituximab Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rituximab Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Rituximab Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Rituximab Drug Sales Share by Type (2018-2024)
Table 30. Global Rituximab Drug Sales Share by Type (2024-2029)
Table 31. Global Rituximab Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Rituximab Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Rituximab Drug Revenue Share by Type (2018-2024)
Table 34. Global Rituximab Drug Revenue Share by Type (2024-2029)
Table 35. Rituximab Drug Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Rituximab Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Rituximab Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Rituximab Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Rituximab Drug Sales Share by Application (2018-2024)
Table 40. Global Rituximab Drug Sales Share by Application (2024-2029)
Table 41. Global Rituximab Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Rituximab Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Rituximab Drug Revenue Share by Application (2018-2024)
Table 44. Global Rituximab Drug Revenue Share by Application (2024-2029)
Table 45. Rituximab Drug Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Rituximab Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Rituximab Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Rituximab Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Rituximab Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Rituximab Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Rituximab Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Rituximab Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Rituximab Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Rituximab Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Rituximab Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Rituximab Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Rituximab Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Rituximab Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Rituximab Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Rituximab Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Rituximab Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Rituximab Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Rituximab Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Rituximab Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Rituximab Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Rituximab Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Rituximab Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Rituximab Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Rituximab Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Rituximab Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Rituximab Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Rituximab Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Rituximab Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Rituximab Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Rituximab Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Rituximab Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Rituximab Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Rituximab Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Rituximab Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Rituximab Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Rituximab Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Rituximab Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Rituximab Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Rituximab Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Rituximab Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Rituximab Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Rituximab Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Rituximab Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Rituximab Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Rituximab Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Rituximab Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Rituximab Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Rituximab Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Rituximab Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Rituximab Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Rituximab Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Rituximab Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Rituximab Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Rituximab Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Rituximab Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Rituximab Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Rituximab Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Rituximab Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rituximab Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Rituximab Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Rituximab Drug Sales by Country (2024-2029) & (K Units)
Table 107. Roche Company Information
Table 108. Roche Description and Major Businesses
Table 109. Roche Rituximab Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Roche Rituximab Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Roche Recent Developments
Table 112. Teva Company Information
Table 113. Teva Description and Major Businesses
Table 114. Teva Rituximab Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Teva Rituximab Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Recent Developments
Table 117. Pfizer Company Information
Table 118. Pfizer Description and Major Businesses
Table 119. Pfizer Rituximab Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Pfizer Rituximab Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer Recent Developments
Table 122. Amgen Company Information
Table 123. Amgen Description and Major Businesses
Table 124. Amgen Rituximab Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Amgen Rituximab Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Amgen Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Rituximab Drug Distributors List
Table 130. Rituximab Drug Customers List
Table 131. Rituximab Drug Market Trends
Table 132. Rituximab Drug Market Drivers
Table 133. Rituximab Drug Market Challenges
Table 134. Rituximab Drug Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Rituximab Drug Product Picture
Figure 2. Global Rituximab Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rituximab Drug Market Share by Type in 2022 & 2029
Figure 4. 500mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Rituximab Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Rituximab Drug Market Share by Application in 2022 & 2029
Figure 8. Intravenous Use
Figure 9. Subcutaneous Use
Figure 10. Rituximab Drug Report Years Considered
Figure 11. Global Rituximab Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Rituximab Drug Revenue 2018-2029 (US$ Million)
Figure 13. Global Rituximab Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Rituximab Drug Revenue Market Share by Region (2018-2029)
Figure 15. Global Rituximab Drug Sales 2018-2029 ((K Units)
Figure 16. Global Rituximab Drug Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Rituximab Drug Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Rituximab Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Rituximab Drug Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Rituximab Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Rituximab Drug Sales YoY (2018-2029) & (K Units)
Figure 22. China Rituximab Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Rituximab Drug Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Rituximab Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Rituximab Drug Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Rituximab Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Rituximab Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Rituximab Drug in the World: Market Share by Rituximab Drug Revenue in 2022
Figure 29. Global Rituximab Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Rituximab Drug Sales Market Share by Type (2018-2029)
Figure 31. Global Rituximab Drug Revenue Market Share by Type (2018-2029)
Figure 32. Global Rituximab Drug Sales Market Share by Application (2018-2029)
Figure 33. Global Rituximab Drug Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Rituximab Drug Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Rituximab Drug Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Rituximab Drug Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Rituximab Drug Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Rituximab Drug Revenue Share by Country (2018-2029)
Figure 39. US & Canada Rituximab Drug Sales Share by Country (2018-2029)
Figure 40. U.S. Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Rituximab Drug Sales Market Share by Type (2018-2029)
Figure 43. Europe Rituximab Drug Revenue Market Share by Type (2018-2029)
Figure 44. Europe Rituximab Drug Sales Market Share by Application (2018-2029)
Figure 45. Europe Rituximab Drug Revenue Market Share by Application (2018-2029)
Figure 46. Europe Rituximab Drug Revenue Share by Country (2018-2029)
Figure 47. Europe Rituximab Drug Sales Share by Country (2018-2029)
Figure 48. Germany Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 49. France Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 50. UK Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 53. China Rituximab Drug Sales Market Share by Type (2018-2029)
Figure 54. China Rituximab Drug Revenue Market Share by Type (2018-2029)
Figure 55. China Rituximab Drug Sales Market Share by Application (2018-2029)
Figure 56. China Rituximab Drug Revenue Market Share by Application (2018-2029)
Figure 57. Asia Rituximab Drug Sales Market Share by Type (2018-2029)
Figure 58. Asia Rituximab Drug Revenue Market Share by Type (2018-2029)
Figure 59. Asia Rituximab Drug Sales Market Share by Application (2018-2029)
Figure 60. Asia Rituximab Drug Revenue Market Share by Application (2018-2029)
Figure 61. Asia Rituximab Drug Revenue Share by Region (2018-2029)
Figure 62. Asia Rituximab Drug Sales Share by Region (2018-2029)
Figure 63. Japan Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 67. India Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Rituximab Drug Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Rituximab Drug Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Rituximab Drug Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Rituximab Drug Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Rituximab Drug Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Rituximab Drug Sales Share by Country (2018-2029)
Figure 74. Brazil Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Rituximab Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Rituximab Drug Value Chain
Figure 80. Rituximab Drug Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries